
Using Artificial Intelligence to Facilitate Cancer Therapy Development
Investigating an approach to improve the prediction of how cancers might respond to targeted therapy.

Discovering A New Target for Diabetes Treatment
Diabetes, the seventh leading cause of death in the US, is a chronic illness that affects over 37 million Americans.

Identifying Targets for Pain Medication with Artificial Intelligence
Chronic pain, a condition where pain persists or recurs over a long period of time, is common in the US, affecting an estimated 1 in 5 adults.

Feeling sleepy? New ways to understand how our bodies rest
While there are many factors that help animals sleep, a driving component is known as the circadian rhythm. This rhythm is a set of physical, mental…

Investigators in the IDG Consortium have Mapped out the Targets of Every FDA Approved Drug
The vast majority of drugs approved by the FDA act through binding to and changing the activity of protein targets.
Publications from IDG Investigators: Exploring the Druggable Genome
A recent paper published in Nature by IDG grantees Brian Shoichet and Bryan Roth, suggests combining physical and structure-based screening as a…
This page last reviewed on November 8, 2023